Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
71.63
+0.09 (0.13%)
Dec 5, 2025, 4:00 PM EST - Market closed
Avidity Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -549.79 | -322.3 | -212.22 | -174 | -118.01 | -44.36 | |
| Depreciation & Amortization | 3.39 | 2.78 | 2.1 | 1.39 | 0.64 | 0.37 | |
| Loss (Gain) From Sale of Investments | -18.2 | -21.45 | -11.27 | -0.62 | 0.18 | 0.01 | |
| Stock-Based Compensation | 68.57 | 51.36 | 38.22 | 27.14 | 17.06 | 4.31 | |
| Other Operating Activities | 3.5 | 3.3 | 2.98 | 2.75 | 0.68 | 0.21 | |
| Change in Accounts Payable | 37.44 | 35.18 | 1.77 | 18.32 | 6.04 | 5.75 | |
| Change in Unearned Revenue | -10.73 | -10.32 | 62.99 | -5.12 | -4.44 | -3.1 | |
| Change in Other Net Operating Assets | -114.8 | -39.43 | -3.63 | -6.13 | 3.04 | -0.32 | |
| Operating Cash Flow | -580.54 | -300.87 | -119.06 | -136.27 | -94.81 | -37.12 | |
| Capital Expenditures | -11.72 | -7.07 | -4.23 | -2.82 | -3.74 | -1.09 | |
| Investment in Securities | -294.53 | -847.14 | -125.84 | -187.13 | -78.78 | -6.69 | |
| Investing Cash Flow | -309.43 | -854.2 | -130.07 | -189.96 | -82.52 | -7.79 | |
| Long-Term Debt Repaid | - | - | - | - | - | -4.68 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -4.68 | |
| Issuance of Common Stock | 869.8 | 1,051 | 93.86 | 346.17 | 176.32 | 274.52 | |
| Other Financing Activities | - | 141.4 | - | - | - | - | |
| Financing Cash Flow | 869.8 | 1,192 | 93.86 | 346.17 | 176.32 | 272.04 | |
| Net Cash Flow | -20.03 | 37.29 | -155.27 | 19.95 | -1.01 | 227.14 | |
| Free Cash Flow | -592.26 | -307.94 | -123.29 | -139.09 | -98.55 | -38.21 | |
| Free Cash Flow Margin | -2838.14% | -2825.88% | -1289.66% | -1507.92% | -1056.76% | -562.97% | |
| Free Cash Flow Per Share | -4.51 | -2.76 | -1.69 | -2.67 | -2.38 | -1.76 | |
| Cash Interest Paid | - | - | - | - | - | 0.57 | |
| Levered Free Cash Flow | -301.07 | -197.47 | -86.66 | -71.82 | -48.59 | -19.53 | |
| Unlevered Free Cash Flow | -301.07 | -197.47 | -86.66 | -71.82 | -48.59 | -19.4 | |
| Change in Working Capital | -88.09 | -14.56 | 61.13 | 7.07 | 4.64 | 2.33 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.